|
EIF3J expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.766900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.396000E-04 |
| Normal-vs-Stage2 |
1.192150E-02 |
| Normal-vs-Stage3 |
7.782400E-02 |
| Normal-vs-Stage4 |
9.242800E-01 |
| Stage1-vs-Stage2 |
9.066800E-01 |
| Stage1-vs-Stage3 |
5.220000E-01 |
| Stage1-vs-Stage4 |
8.600200E-02 |
| Stage2-vs-Stage3 |
5.607200E-01 |
| Stage2-vs-Stage4 |
9.530300E-02 |
| Stage3-vs-Stage4 |
2.354400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.572200E-04 |
| Normal-vs-AfricanAmerican |
8.544400E-02 |
| Normal-vs-Asian |
7.685800E-01 |
| Caucasian-vs-AfricanAmerican |
1.446970E-01 |
| Caucasian-vs-Asian |
4.186200E-01 |
| AfricanAmerican-vs-Asian |
7.879000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.82580000000532E-05 |
| Normal-vs-Female |
2.069600E-01 |
| Male-vs-Female |
7.344600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.075800E-03 |
| Normal-vs-Extreme_Weight |
2.395300E-04 |
| Normal-vs-Obese |
2.756100E-02 |
| Normal-vs-Extreme_Obese |
1.040350E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.914600E-01 |
| Normal_Weight-vs-Obese |
3.874800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.264600E-01 |
| Extreme_Weight-vs-Obese |
2.330200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.640000E-01 |
| Obese-vs-Extreme_Obese |
4.035800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.673400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.294400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.34990000000024E-05 |
| Normal-vs-Age(81-100Yrs) |
2.777300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.136400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.189650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.295800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.536240E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.943500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.205000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.220800E-04 |
| Normal-VS-Type2 PRCC |
2.183000E-03 |
| Normal-VS-KIRP CIMP |
6.736200E-01 |
| Normal-VS-Unclassified PRCC |
6.644300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.378000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.136400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.919000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.067900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.643400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.762360E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79085999999495E-05 |
| Normal-vs-N1 |
9.899400E-01 |
| Normal-vs-N2 |
1.346490E-02 |
| N0-vs-N1 |
7.437800E-03 |
| N0-vs-N2 |
7.391200E-01 |
| N1-vs-N2 |
1.627160E-01 |
|
|
